The next big pandemic: Sepsis and Antibiotic Resistance Management, an increasing need for better screening and diagnostics

Speaker - Funded(s)

• 

  Hjalmar Bouma, MD, PhD, EuCP (he/him/his)

  Consultant Internal Medicine-Acute Medicine/Pharmacology
  University Medical Center Groningen
  Groningen, Groningen, Netherlands
• 

  Dimitris Tsiokos

  CEO
  Bialoom Ltd
  Engomi, Nicosia, Cyprus

Speaker - Tony B. Awardee(s)

• 

  Sunghyun Ki (he/him/his)

  Graduate student (Ph.D. candidate)
  Incheon National University
  Incheon, Inch'on-jikhalsi, Republic of Korea

Blood cultures have been the staple of screeing and diagnostics laboratories for well over half a century, but gaps remain in our ability to identify the causative agent in patients presenting with signs and symptoms of one of the major common and unresolved causes of death: Sepsis. Moreoveover, The inability to accurately diagnose the exact pathogen causing an infection often leads to broad-spectrum or inappropriate antibiotic prescribing. This adds unnecessary cost and promotes the development of antibiotic resistance, being one of the biggest threats for the whole human population during the next decades. In this session, we will tackle how new molecular technologies fueled with Machine learning and AI can help overcome these challenges in the near future.

Presentations:

• 14:30 – 15:00 CEST

  Enhancing Sepsis Recognition and Treatment: A Multifaceted Personalized Approach
  

  Hjalmar Bouma, MD, PhD, EuCP (he/him/his) – University Medical Center Groningen
• 15:00 – 15:30 CEST

  Transforming point-of-care diagnostics: The power of silicon plasmonic biosensors in the battle against acute infections
  

  Dimitris Tsiokos – Bialoom Ltd
• 15:30 – 16:00 CEST

  Integration of wide-field imaging system with droplet microfluidics for monitoring living bacteria
  

  Sunghyun Ki (he/him/his) – Incheon National University